Skip to content

ZECERP

Home
Products
ZECERP
Zecerp - Zengenta Pharmaceuticals Ltd

ZECERP

Cerebroprotein Hydrobtsate 90 mg. + Vit. B12 0.5 mg. + Vit. B6 1.3 mg + Vit. B1 1.1 mg. + Omega 3 100 mg. Capsules

THERAPEUTIC INDICATIONS
  • Cranial Injury
  • Cerebrovascular pathological sequelae
  • Aprosexia in dementia
  • Mental problems
  • Neurological disurance
  • Convulsions
  • Pernicious anemia
  • Reduce triglyceride (TG) levels
  • Thiamine deficiency
  • Neurological disorders
POSOLOGY AND METHOD OF ADMINISTRATION
  • Adults (including elderly):One Capsule Two times daily.
The daily dose of ZECERP Capsules is 4 capsules per day taken or 2 capsules doses twice daily.
  • Pediatric Population: Should not be used in children.
METHOD OF ADMINISTRATION: Oral CONTRAINDICATIONS: Hypersensitivity to the active substance or to any of the excipients. Hypersensitivity to the active substance or to any of the excipients. Special warnings and precautions for use Special care is indicated in following cases:
  • Allergic diathesis.
  • Epileptic conditions and grand mai convulsions; Cerebroprotein Hydrolysate treatment may result in an increase in the frequency of seizures.
  • Although there are no indications that Cerebroprotein Hydrolysate, causes renal stress, the product should not be administered in the presence of existing severe renal insufficiency
  • Patients who take cerebroprotein Hydrolysate treatment Should not arve vehicles or operate machines to avoid any possible risk, through no medical evidence show that cerebroprotein Hydrolysate can reduce one's reactions to these activities.